Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Abstract

Aim: Eligibility for liver transplantation for hepatocellular carcinoma (HCC) is currently based on single-dimension, diameter measurements on cross-sectional imaging, as specified by various selection criteria. This does not account for significant differences in shape, and therefore tumour volume, between patients. This study investigated whether one-dimensional selection criteria disadvantages patients by not considering volume.

Methods: Patient data were collected retrospectively from a prospectively maintained database. Tumours were measured on both computer tomography (CT) and magnetic resonance imaging (MRI). Tumour volume was measured using two methods; semi-automated planimetry and the ellipsoid volume formula. Statistical analysis was performed using SPSS.

Results: A total of 313 patients with HCC were assessed for liver transplantation. For this study, patients who underwent transplantation (n = 89) and those who did not based on tumour size (n = 33) were included. In total, 213 tumours were measured, showing excellent correlation between CT and MRI (R² = 0.83). The majority of tumour nodules (94%) were ellipsoid not spherical. Volumetric measurements of the 84 tumours that did not meet diameter-based Milan criteria confirmed that 76% would have been within a theoretical volume allowance based on Milan criteria diameters.

Conclusion: This study shows that a significant number of patients deemed outside conventional diameter-based Milan criteria have smaller tumour volumes than those considered within criteria. It appears that those with ellipsoid rather than spherical tumours may be disadvantaged by current size-based criteria. Further research using a contemporary patient cohort who have had the benefit of advancements in non-surgical treatments for HCC is required.

Keywords

Hepatocellular carcinoma / liver transplantation / Milan criteria / HCC measurement

References

[1] Bray F,Soerjomataram I,Torre LA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries..CA Cancer J Clin2018;68:394-424

[2] Rawla P,Muralidharan P.Update in global trends and aetiology of hepatocellular carcinoma..Contemp Oncol (Pozn)2018;22:141-50 PMCID:PMC6238087

[3] Forner A,Bruix J.Hepatocellular carcinoma..Lancet2012;379:1245-55

[4] Bruix J.Major achievements in hepatocellular carcinoma..Lancet2009;373:614-6

[5] Ayuso C,García-Criado A.Imaging of HCC..Abdom Imaging2012;37:215-30

[6] Choi BI.Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma..J Hepatobiliary Pancreat Sci2010;17:369-73

[7] Llovet JM,Bruix J.Hepatocellular carcinoma..Lancet2003;362:1907-17

[8] Forner A,Bruix J.Hepatocellular carcinoma..Lancet2018;391:1301-14

[9] Befeler AS.Hepatocellular carcinoma: diagnosis and treatment..Gastroenterology2002;122:1609-19

[10] Llovet JM,Bruix J.The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma..Liver Transpl2004;10:S115-20

[11] Mazzaferro V,Doci R.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis..N Engl J Med1996;334:693-9

[12] Duffy JP,Benjamin E.Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA..Ann Surg2007;246:502-9discussion 509-11 PMCID:PMC1959350

[13] Therasse P,Eisenhauer EA.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada..J Natl Cancer Inst2000;92:205-16

[14] Fleckenstein FN,Duran R.3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival..Eur Radiol2016;26:3243-52 PMCID:PMC4942412

[15] Prasad SR,Saini S,Halpern EF.CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations..Radiology2002;225:416-9

[16] Lee YH,Hsu CY,Lin HC.Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria..World J Surg2013;37:1348-55

[17] Welsh JL,Fallon E,Buatti JM.Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma..Am J Surg2012;204:580-5 PMCID:PMC3496005

[18] Delis SG,Tassopoulos N.Hepatic resection for hepatocellular carcinoma exceeding Milan criteria..Surg Oncol2010;19:200-7

[19] Macaron C,Lopez R,Zein NN.Total tumor volume predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria..Transplant Proc2010;42:4585-92

[20] Zakaria HM,Gaballa NK.Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study..Ann Med Surg (Lond)2020;54:47-53 PMCID:PMC7184266

[21] Lencioni R.Surveillance and early diagnosis of hepatocellular carcinoma..Dig Liver Dis2010;42:S223-7

[22] Chen HY,Ma XM,Ye M.CT and MRI in target delineation in primary hepatocellular carcinoma..Cancer Radiother2013;17:750-4

[23] Li C,Yan LN.Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation..PLoS One2013;8:e72235 PMCID:PMC3749102

[24] Lagendijk M,Ramlakhan KP.Breast and tumour volume measurements in breast cancer patients using 3-D automated breast volume scanner images..World J Surg2018;42:2087-93 PMCID:PMC5990576

[25] Stuppner S,Ruiu A.Gross tumour volume comparison in oropharynx carcinomas using different intelligent imaging software. A retrospective analysis..Pol J Radiol2020;85:e287-92 PMCID:PMC7361371